Showing results (1301-1310 of 1,431) with videos related to

Sort By:
Pageof 144
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 28, 2022
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit StudyYeh Chen Lee, Madeleine T King, Rachel L O'Connell, et al.
Cancer|May 13, 2021
Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
The Journal of Infectious Diseases|April 11, 2014
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Cancer|August 19, 2020
Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2020
Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapyAngelina Tjokrowidjaja, Chee K Lee, Michael Friedlander, et al.
Epidemiology and Infection|November 28, 2012
Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011J Nielsen, A Mazick, N Andrews, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancerChristian Marth, Ignace Vergote, Giovanni Scambia, et al.
Journal of Medicinal Chemistry|December 11, 2013
Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)Edward J Hennessy, Ammar Adam, Brian M Aquila, et al.
The Lancet. Oncology|June 18, 2021
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 studyEric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A Ledermann, et al.
Nature Medicine|February 14, 2025
Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trialIsabel Deisenhofer, Jean-Paul Albenque, Sonia Busch, et al.
Pageof 144